Redmond Asset Management’s AbbVie ABBV Stock Holding History

Redmond Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96M	Sell	7,808 -249	-3%	-$53.6K	0.49%	70
2026 Q1	$1.75M	Sell	8,057 -85	-1%	-$18.9K	0.48%	77
2025 Q4	$1.86M	Sell	8,142 -75	-0.9%	-$17.1K	0.47%	73
2025 Q3	$1.9M	Sell	8,217 -570	-6%	-$116K	0.47%	76
2025 Q2	$1.63M	Sell	8,787 -420	-5%	-$78.1K	0.39%	90
2025 Q1	$1.93M	Buy	9,207 +75	+0.8%	+$14.6K	0.5%	67
2024 Q4	$1.62M	Buy	+9,132	New	+$1.68M	0.41%	86
2014 Q1	–	Sell	-10,826	Closed	-$572K	–	143
2013 Q4	$572K	Buy	10,826 +2,000	+23%	+$98.3K	0.3%	90
2013 Q3	$395K	Buy	8,826 +2,950	+50%	+$131K	0.23%	105
2013 Q2	$243K	Buy	+5,876	New	+$257K	0.18%	100

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Redmond Asset Management's ABBV Position: Q2 2026 in Review

Redmond Asset Management reduced its AbbVie (ABBV) stake by 3.1% in Q2 2026, selling an estimated $53.6K and leaving 7,808 shares worth $1.96M. The position accounts for 0.49% of the portfolio, ranked #70.

Redmond Asset Management first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Redmond Asset Management held 7,808 shares of AbbVie worth $1.96M as of Q2 2026.
Redmond Asset Management sold 249 AbbVie shares in Q2 2026, an estimated $53.6K.
AbbVie made up 0.49% of Redmond Asset Management's portfolio in Q2 2026, its #70 holding.
Redmond Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Redmond Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.